Salt Therapy Association hosts live and virtual conference featuring leading research and education—Showcases massive growth of salt therapy across the globe
BOCA RATON, Fla., Sept. 22, 2022 /PRNewswire/ — The Salt Therapy Association the leading educational trade association for the halotherapy industry, hosted its 5th annual conference on September 12-13 at the Wyndham® Lake Buena Vista Disney Springs™ Resort in Orlando. The event brought together over 250 attendees from 10 countries and featured 20 prominent wellness, spa, halotherapy, and business management professionals speaking on a variety of leading-edge topics. Recurring themes were reaching the industry inflection point and the evolution of salt therapy as a foundation of respiratory wellness.
Opening keynotes included Susie Ellis, Co-Founder, Chair & CEO of the Global Wellness Institute (GWI) and Global Wellness Summit speaking on “The Future of the Wellness Industry,” and Dr. John Ryan, Chief Strategy Officer of Allergy Standards Ltd., and Vice Chair of the GWI Respiratory Wellness Initiative, on “Trends impacting Global Respiratory Wellness.”
Ellis remarked, “I very much enjoyed the conference and left feeling that I learned a great deal about the entire ecosystem of salt therapy and the many ways it contributes to health and wellbeing programs.”
“There is a growing awareness of how the quality of the air we breathe impacts our health,” said STA Founding Director Leo Tonkin, CEO of SALT Chamber and Initiative Chair of the GWI Respiratory Wellness Initiative. “Our speakers and attendees have shifted their focus to improving their clients’ respiratory wellness, which directly improves the quality of life.”
Shoshana Treichel, a presenter and owner of Above and Beyond Yoga and Salt Therapy Center, added, “The 5th annual STA Conference was the best yet—attendees walked away with great practical information on how to successfully run a salt therapy business, as well as global trends and perspectives.”
The STA announced several new initiatives in the coming months, including the next generation of certification standards, version 2.0 of the STA Certified Halotherapist Program (over 400+ certified now), continued research, and new studies.
“STAcon validated that not only is the recovery wellness sector exploding, but that salt therapy is at its forefront,” concluded Hensley Ellefritz, a presenter and owner of Reboot Fitness Consulting.
About Salt Therapy Association
The Salt Therapy Association (STA) is a nonprofit 501(c)(6) organization founded in 2014 to provide resources, information, research, and standards for the industry, businesses, and consumers. With over 3,800 members in 35 countries, STA is the largest organization of salt therapy facilities, professionals, and enthusiasts in the world.
CONTACT: Membership Director: Adam Loss, info@salttherapyassociation.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/stacon-live-2022-the-growing-impact-of-salt-therapy-on-respiratory-wellness-301631469.html
SOURCE Salt Therapy Association
Shares of Biogen (NASDAQ: BIIB) shot up as much as 37.1% this week, according to data from S&P Global Market Intelligence. The large-cap drugmaker with a market cap of $39 billion announced that its new Alzheimer's drug it developed in a partnership with Eisai showed tremendous promise in a clinical trial. As of 12:42 p.m. ET on Friday, shares of Biogen were up 35.5% this week.
If you're enrolled in Medicare, you should know that open enrollment will soon kick off. Each year, seniors on Medicare can make changes to their existing coverage, from Oct. 15 all the way through Dec. 7. Medicare Advantage and Part D drug plans can change from year to year.
Intercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis, leading ICPT stock to plummet Friday.
The new, redesigned COVID booster, which protects against omicron and its extremely contagious subvariants, appears to have a visibility problem. Federal authorities authorized the shot at the end of August, but by mid- to late September, nearly half of adults had heard little or nothing about it, according to a report by the Kaiser Family Foundation, based on the latest of its monthly surveys about attitudes toward the COVID vaccines. That could have troubling implications. The Biden administra
America’s health care system is not enough, even for those able to obtain health insurance through their employer.
Horizon (HZNP) completes enrollment in the phase IV study evaluating Tepezza for the treatment of thyroid eye disease in patients with a low clinical activity score.
A change of seasons is the perfect time to start — or shake up — your fitness routine. Join the October Start TODAY challenge to reap the health benefits of walking.
Alexandria Ocasio-Cortez argued in a congressional hearing on Thursday that the disagreement over abortion rights is a "class struggle."
FORT MYERS, Fla. — Hurricane Ian has created a burgeoning biohazard situation in at least one Florida hospital close to where the storm first made landfall.
A hundred days after the U.S. Supreme Court overturned Roe v. Wade, abortions for out-of-state patients have surged in Illinois, as many Midwestern and Southern states have banned or severely restricted terminating a pregnancy. Before the historic reversal of federal reproductive rights, Planned Parenthood of Illinois used to schedule dozens of abortion patients from other states each month. …
New mom jealousy is real — I had it after my first baby was born. I would feel anxious if other people were holding my newborn too long or if he smiled at other people. I was later diagnosed with postpartum anxiety, and it all made so much sense. Those feelings I had may have […]
The Food and Drug Administration on Thursday approved a new medication for Amyotrophic Lateral Sclerosis (A.L.S), the debilitating and deadly neurological disorder also known as Lou Gehrig’s Disease. On Friday, the drug’s manufacturer, Amylyx Pharmaceuticals, announced the list price of the drug will be $158,000. That list price, Pam Belluck of The New York Times notes, is far higher than the annual price of $9,100 to $30,700 recommended by the Institute for Clinical and Economic Review, a nonpr
Amylyx (AMLX) obtains the FDA's approval for its oral, fixed-dose combination therapy for treating adults with amyotrophic lateral sclerosis (ALS) after a few roadblocks.
Biohaven Pharmaceuticals (BHVN) suffers a setback as verdiperstat fails to meet the primary and secondary endpoints in an ALS study.
Sparrow spokesperson Corey Alexander confirmed the layoffs and said cuts would target leadership and non-patient care roles.
Nursing homes patients had to be evacuated after Hurricane Ian cut access to safe water supplies. AP Photo/John RaouxHurricane Ian, one of the most powerful storms to hit the U.S., tore part of the roof off a hospital in Port Charlotte, Florida, and flooded the building’s lower level emergency room, sending staff scrambling to move patients as water poured in. At least nine hospitals and dozens of nursing homes had to transfer patients after losing access to clean water because of the storm. Hea
Cholera cases have surged this year, especially in places of poverty and conflict, with outbreaks reported in 26 countries and fatality rates rising sharply, a World Health Organization official said on Friday. In a typical year, fewer than 20 countries report outbreaks of the disease which is spread by the ingestion of contaminated food or water and can cause acute diarrhoea. "After years of declining numbers, we are seeing a very worrying upsurge of cholera outbreaks around the globe over the past year," Philippe Barboza, WHO Team Lead for Cholera, told a press briefing in Geneva.
Amylyx's new treatment for amyotrophic lateral sclerosis received funding raised during 2014's Ice Bucket Challenge.
